RecruitingNCT07636590
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
Sponsor
Claris Biotherapeutics, Inc.
Enrollment
500 participants
Start Date
May 22, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Eligibility
Min Age: 12 YearsMax Age: 99 Years
Inclusion Criteria4
- A photopic BCVA in the prospective study eye(s) of ≤ 70 letters at the Screening and Day 1 visits AND a change of ≤ 10 letters in photopic BCVA at Day 1 compared to the Screening Visit
- Qualifying LSCD diagnosis in the study eye(s) prior to enrollment at Day 1
- Written confirmation that exclusions on retinal findings are met in the study eye(s) prior to enrollment at Day 1
- Inflammation associated with LSCD or other non-infectious inflammation (e.g., dry eye, ocular rosacea, and blepharitis) that will not interfere with the subject's participation in the opinion of the investigator is permitted.
Exclusion Criteria3
- Any active ocular infection in either eye at either the Screening or Day 1 visits
- Active sterile iritis or uveitis in either eye at Screening or Day 1 visits
- Screening visit retinal exam finding, in the opinion of the investigator, that would limit potential for visual acuity gain in the study eye(s)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-interventional
Non-interventional
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07636590
Related Trials
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
NCT064523166 locations
Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma
NCT071195801 location
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
NCT017563654 locations
Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium
NCT062652981 location